Introduction
============

Epithelial ovarian cancer (EOC) is a female malignant tumor with a high mortality rate. In recent years, its incidence has been soaring worldwide.[@b1-cmar-11-2379] EOC lacks significant symptoms in the early stage, leading to poor prognosis, so the biggest challenge of curing EOC is early diagnosis.[@b2-cmar-11-2379] Surgical and adjuvant therapies have limited function in improving the prognosis for advanced EOC, and there is growing evidence that targeted therapy for specific biological factors has greater value.[@b3-cmar-11-2379]

Gene expression profiling has been widely applied to screen and analyze genes in linkage to various types of cancer progression,[@b4-cmar-11-2379],[@b5-cmar-11-2379] and researchers have used a comprehensive approach to further explore the changes in biological factors in the development of EOC.[@b6-cmar-11-2379] Many genes with similar expression patterns affect each other and even have a regulatory relationship.[@b7-cmar-11-2379] Most studies only focus on the differential expression of genes, but ignore the connection between genes. Weighted Gene Expression Network Analysis (WGCNA) is a systematic biological method which is utilized to describe the pattern of gene association between different samples.[@b7-cmar-11-2379],[@b8-cmar-11-2379] It can be used to identify highly synergistically altered gene sets and to identify candidate biomarker genes or therapeutic targets based on the association of gene sets and associations between gene sets and phenotypes. Recently, WGCNA has been comprehensively used in cancer-related research.[@b9-cmar-11-2379] For instance, Zhou et al[@b10-cmar-11-2379] revealed that *TOP2A* might be used as a potential biological target for the prognosis and progression of pancreatic ductal adenocarcinoma. Wang et al[@b12-cmar-11-2379] found that the abnormal spindle-like microcephaly gene (*ASPM*), the human ortholog of the Drosophila melanogaster "abnormal spindle" gene (*asp*), encodes ASPM, a protein localized at the centrosome of apical neuroprogenitor cells and involved in spindle pole positioning during neurogenesis, and may cause cirrhosis, then further produce hepatocellular carcinoma. In this research, we first screened differentially expressed genes (DEGs) using WGCNA-based systems biology methods, and then constructed a protein--protein interaction (PPI) network and a co-expression network of genes, to discover the essential genes and pathways involved in the carcinogenic mechanism of EOC.[@b13-cmar-11-2379]

Materials and methods
=====================

Data collection
---------------

We downloaded the gene expression profile from the Gene Expression Omnibus (GEO) database (<http://www.ncbi.nlm.nih.gov/geo/>), Dataset GSE18520[@b14-cmar-11-2379] and GSE27651[@b15-cmar-11-2379] ([Table S1](#SD1-cmar-11-2379){ref-type="supplementary-material"}) were processed by Affymetrix Human Genome U133 Plus 2.0 Array \[transcript (gene) version\] (Affymetrix, Santa Clara, CA, USA).[@b16-cmar-11-2379] We used the processed data to filter DEGs, and set up PPI networks and co-expression networks in order to identify hub genes and pathways in this research. Dataset GSE18520 included 10 normal ovarian tissue samples and 53 high-grade primary EOC tissue samples. Dataset GSE27651 included 6 normal ovarian tissue samples and 43 EOC tissue samples including 8 microdissected serous borderline ovarian tumor tissue samples, 13 low-grade serous ovarian carcinomas tissue samples and 22 high-grade serous ovarian carcinomas tissue samples. The genomic data and clinical data of EOC from The Cancer Genome Atlas (TCGA; <https://cancergenome.nih.gov/>) were also downloaded. These RNA sequencing data from Illumina HiSeq RNASeq platform included 379 tumor sample specimens from patients with EOC. There were no normal ovarian tissue samples in the TCGA database.

Research design and data preprocessing
--------------------------------------

The research was designed according to the flowchart ([Figure 1](#f1-cmar-11-2379){ref-type="fig"}). These two datasets were chosen for integrated analysis because they have the same platform and are crucial for combining data from different datasets. The raw data for these two datasets were integrated for the analysis, including RMA background correction,[@b17-cmar-11-2379] log2 transformation, quantile normalization and median polish algorithm summarization by the "affy" R language package.[@b18-cmar-11-2379] The microarray data probe was transformed to gene symbols with Bioconductor Annotation Data software packages. If several probes were mapped to one gene symbol, the mean value was set as the final expression value of this gene. The combat function in the sva package was applied to remove the batch effects of these two datasets[@b19-cmar-11-2379] ([Table S2](#SD1-cmar-11-2379){ref-type="supplementary-material"}). Microarray quality was evaluated by sample clustering in light of the distance between different samples in Pearson' s correlation matrices.[@b20-cmar-11-2379] GSM461376 were removed from subsequent analysis in the test dataset. ([Figure S1](#SD1-cmar-11-2379){ref-type="supplementary-material"}).

Differentially expressed genes
------------------------------

We utilized the "limma" R language package[@b21-cmar-11-2379] to screen the DEGs between EOC samples and normal ovarian samples. The adjusted *P*\<0.05 and \|log2fold change (FC)\|\>1 were chosen as the cutoff criteria. Adjusted *P*-value (adj. *P*) was applied to help correct false-positives. Drawing of heatmap was performed through the "heatmap" package in R 3.4.4[@b22-cmar-11-2379]

Gene ontology (GO) term and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis
------------------------------------------------------------------------------------------------------

The KEGG is a reference knowledge base involving systems information, genomic information and chemical information. GO is a framework for the model of biology, which describes gene functions and classifies. To further explore the biological significance of DEGs, we used a package called Clusterprofiler[@b23-cmar-11-2379] with the ability to analyze and visualize data to perform enrichment analysis of functions and pathways.[@b23-cmar-11-2379] *P*-value \<0.05 was considered a significant enrichment.

Comprehensive analysis of PPI network and functional analysis
-------------------------------------------------------------

We used Search Tool for the Retrieval of Interacting Genes Database (STRING) (<http://www.string-db.org/>) to assess PPI information.[@b24-cmar-11-2379] In addition, in order to explore the relationship between DEGs, we used the STRING database for analysis, and visually converted the results using Cytoscape software. The "Experiments" and "Databases" sources have been used for building the network, and we have set the threshold for interaction score at 0.95, which indicated the highest confidence of two protein interaction occurrences. The Cytoscape Molecular Complex Detection (MCODE) plug-in was used for searching clustered sub-networks.[@b25-cmar-11-2379] The default parameters were as follows: degree cutoff =5, node score cutoff =0.2, k-core =2, and max. depth =100. Next we used the Clusterprofiler to perform functional analysis of the genes in the hub module.

Co-expression network creation and module functional analysis
-------------------------------------------------------------

The first step was to test the expression data profile of the DEGs to see if they were suitable samples and genes. Next, we used the WGCNA[@b11-cmar-11-2379] package in the R language to create the co-expression network for DEGs.[@b26-cmar-11-2379],[@b27-cmar-11-2379] The Pearson' s correlation matrices were both functioned for all pair-wise genes. After that, a power function a~mn~ = \|c~mn~\|β (c~mn~ = Pearson' s correlation between gene m and gene n; a~mn~ = adjacency between gene m and gene n) was utilized to erect a weighted adjacency matrix. We used a soft-thresholding parameter β=15 (scale free *R*^2^=0.84) to emphasize strong correlations between genes and penalize weak correlations. Then, we converted the adjacency to topological overlap matrix (TOM) to measure network connectivity of a gene which was defined as the sum of its adjacency with all other genes for network generation. We created average linkage hierarchical clustering due to the TOM-based dissimilarity measure with a minimum size (gene group) of 20 for the gene dendrogram, thereby classifying genes with similar expression profiles into the same gene module. Eigengenes were the principal components of microarray gene expression data, which represented the oscillatory characteristics of gene expression patterns.[@b28-cmar-11-2379] We calculated the dissimilarity of module eigengenes, selected a cut line for module dendrogram, and merged some modules. In order to find relevant modules that have an impact on EOC, we further conducted functional enrichment analysis on these gene modules.

Validation of hub genes
-----------------------

The key genes were identified as the intersecting genes of the turquoise module in WGCNA and DEGs. Survival analysis was performed using a standard Kaplan--Meier univariate curve through the "survival" package in R 3.4.4. *P*-value \<0.05 was considered as having statistical significance. The hub gene was finally validated in GEPIA (Gene Expression Profiling Interactive Analysis).[@b29-cmar-11-2379] GEPIA is a web-based tool to deliver fast and customizable functionalities based on TCGA and Genotype-Tissue Expression databases data.

Preparation for human EOC samples
---------------------------------

During the course of the study, we received informed consent for tissue sample analysis for each patient and were approved by the Institutional Review Board of Nanjing Medical University. Once the tissue of the EOC patient was removed, it was immediately stored at --80°C until use. From June 2017 to January 2018, the Department of Gynecology and Obstetrics, the First Affiliated Hospital of Nanjing Medical University, removed tissue samples from patients with informed consent, including 17 EOC tissues and 10 normal ovarian tissues.

Quantitative real-time RT-PCR (qRT-PCR) analysis
------------------------------------------------

We extracted total RNA from tissue samples using TRizol reagent (Thermo Fisher Scientific, Waltham, MA, USA). We used the Agilent Bioanalyzer 2,100 with RNA 6000 Nano kit (Agilent Technologies, Santa Clara, CA, USA) to assess the integrity of the isolated RNA. We used the high-capacity cDNA reverse transcription kits (Thermo Fisher Scientific) to react RNA, synthesize single-stranded cDNA from RNA, and then perform real-time quantification using the SYBR Green PCR kit (Thermo Fisher Scientific). The cycle threshold (Ct) of each gene was recorded. The relative expression of *ITLN1* was calculated using the 2^−ΔΔCt^ method (ΔCt = Cttarget gene -- Ctinternal control). The forward primer of *ITLN1* is ACGTGCCCAATAAGTCCCC. The reverse primer of *ITLN1* is CCGTTGTCAGTCCAACACTTTC. All procedures for qRT-PCR are performed according to the manufacturer's protocol.

Statistical analyses
--------------------

All analyses were conducted three times and represent data from three separate experiments. Two-tailed Student's *t*-test was utilized for significance of differences between subgroups. Statistical analysis processed via SPSS 16.0 (SPSS Inc., Chicago, IL, USA) and R software 3.4.4 (<https://www.r-project.org/>). Graphs were generated using Graph-Pad Prism 6.0 (GraphPad Software, Inc., La Jolla, CA, USA). Statistical significance was set at probability values of *P*\<0.05.

Results
=======

Identification of DEGs in EOC and the enrichment of these genes
---------------------------------------------------------------

After preprocessing and removing batch effects, we ana-lyzed the DEGs of GSE18520 and GSE27651 using the limma package, using adjusted *P*\<0.05 and \|logFC\| \>1 as the cutoff criterion. We screened 1,700 DEGs, including 943 upregulated genes and 757 downregulated genes in EOC samples compared to normal ovarian samples ([Figure 2A](#f2-cmar-11-2379){ref-type="fig"}). We identified the top 100 DEGs according to \|logFC\| \>1 and then displayed on a heatmap ([Figure 2B](#f2-cmar-11-2379){ref-type="fig"}, [Table S3](#SD1-cmar-11-2379){ref-type="supplementary-material"}). The Clusterprofiler package was applied to compare gene clusters according to their enriched biological processes, with a cutoff criterion of *P*\<0.05 on the 1,700 DEGs ([Table S4](#SD1-cmar-11-2379){ref-type="supplementary-material"}). In GO analysis, the upregulated genes were mostly enriched in phosphate ion binding ([Figure 2C](#f2-cmar-11-2379){ref-type="fig"}), and the downregulated genes were highly enriched in glycosaminoglycan binding, heparin binding and sulfur compound binding ([Figure 2D](#f2-cmar-11-2379){ref-type="fig"}). The KEGG is a reference knowledge base involving systems information, genomic information and chemical information. Using the Clusterprofiler package[@b30-cmar-11-2379] (<http://bioconductor.org/packages/release/bioc/html/clusterProfiler.html>), KEGG pathway enrichment analyses were conducted separately for the DEGs. The upregulated genes were mostly enriched in oxidative phosphorylation and cell cycle ([Figure 2E](#f2-cmar-11-2379){ref-type="fig"}). The downregulated genes were mostly enriched in complement and coagulation cascades, proteoglycans in cancer, histidine metabolism, *Staphylococcus aureus* infection, and tyrosine metabolism ([Figure 2F](#f2-cmar-11-2379){ref-type="fig"}). The above enrichment analysis results can help us further study the role of DEGs in EOC.

PPI network and cluster analysis
--------------------------------

Via the STRING website, 1700 DEGs were screened into the DEGs PPI network complex, which contained 1467 nodes and 185 edges ([Figure 3A](#f3-cmar-11-2379){ref-type="fig"}). With PPI analysis using STRING software, 10 prominent proteins were identified. In these identified proteins, CDK1 was considered to be the most important protein and contacted 11 nodes ([Fig. 3B](#f3-cmar-11-2379){ref-type="fig"}).

After that, we applied the MCODE, a plug-in using scoring and finding parameters that have been optimized to produce the best results for the network, to find clusters in the network. Seven clusters were calculated according to k-core =2. Among them, cluster 1 contained 7 nodes and 21 edges and had the highest score in these clusters ([Figure 4A](#f4-cmar-11-2379){ref-type="fig"}). This result may suggest that the above 7 DEGs play a critical role in EOC. Cluster 2, contained 5 nodes and 10 edges and got the second highest score in these clusters ([Figure 4B](#f4-cmar-11-2379){ref-type="fig"}). The genes in cluster 2 may also be associated with EOC.

Plug-in MCODE was used for the top two significant modules of the PPI network. Because the number of genes in cluster 2 was too small, we only performed functional analysis on the genes in cluster 1. GO and KEGG analysis of module 1 were performed by Clusterprofiler ([Figure 5A and B](#f5-cmar-11-2379){ref-type="fig"}).

Weighted co-expression network construction and analysis
--------------------------------------------------------

As a result, the expression values of the 1,700 genes exhibiting a 1-fold change in the 112 tissues samples were used to construct co-expression modules using the WGCNA algorithms. Hierarchical clustering analysis was performed with the flashClust function and the results are presented in [Figure S1B](#SD1-cmar-11-2379){ref-type="supplementary-material"}. We found one obvious outlier (GSM461376) which was removed from the cohort. The remaining 111 samples were divided into two clusters including normal ovarian tissue samples and EOC tissue samples. GSM462643, GSM462644, GSM462645, GSM462646, GSM462647, GSM462648, GSM462649, GSM462650, GSM462651, GSM462652, GSM372258, GSM372259, GSM372260, GSM372261, GSM372262, and GSM372263 are normal ovarian tissue samples, the rest were EOC tissue samples ([Figure 6A](#f6-cmar-11-2379){ref-type="fig"}). We evaluated the quality for the expression data matrix of GSE18520 and GSE27651, and then used the WGCNA package in the R language to ensure a scalefree network ([Figure S2](#SD1-cmar-11-2379){ref-type="supplementary-material"}). After removing the batch effect, we preprocessed the data and then further analyzed the modules with highly related genes, ten modules were excavated ([Figure 6B](#f6-cmar-11-2379){ref-type="fig"}). We set the MEDissThres as 0.25 to merge similar modules ([Figure 6C](#f6-cmar-11-2379){ref-type="fig"}), and 7 modules were generated. The gray module was a collection of genes that did not belong to any of the functional modules and therefore did not require analysis. Module black contained 161 genes, module blue contained 341 genes, module brown contained 254 genes, module magenta contained 29 genes, and module yellow contained 118 genes. Moreover, an intramodular analysis of GS and MM of the genes in the ten modules was followed. As GS and MM illustrated a very meaningful correlation, this finding indicated that among the top 6 modules, the 325 genes in the turquoise module tend to be remarkably correlated with tumor ([Figure 6D](#f6-cmar-11-2379){ref-type="fig"}). Defined by module connectivity, measured by absolute value of the Pearson's correlation (cor.geneModuleMembership \>0.85) and cancer trait relationship, measured by absolute value of the Pearson's correlation (cor.geneTraitSignificance \>0.2). In the end, 40 hub genes belong to the turquoise module were selected for further research ([Figure 7A](#f7-cmar-11-2379){ref-type="fig"}). Among the modules, module turquoise has the highest negative correlation with cancer traits, and all genes were identified for the heatmap ([Figure 7B](#f7-cmar-11-2379){ref-type="fig"}). The number of genes in each module is shown in [Figure S3](#SD1-cmar-11-2379){ref-type="supplementary-material"}.

Interestingly, some of these gene modules had similar expression profiles. To find out the connections and interactions among these top six co-expressed modules, we analyzed the connectivity of eigengenes. A cluster analysis was completed. In general, six clusters were classified into two clusters, and each contained three branches ([Figure 7C](#f7-cmar-11-2379){ref-type="fig"}). The top 3 relevant modules including the turquoise, brown and black modules were visualized by STRING database and Cytoscape with a combined score \>0.4, which was considered to be meaningful ([Figure 8A-C](#f8-cmar-11-2379){ref-type="fig"}).

GO was performed on these modules in order to explore the potential biological pathway that is correlated to EOC ([Table S5](#SD1-cmar-11-2379){ref-type="supplementary-material"}). In GO analysis, we found that DEGs in the turquoise module were mostly enriched in collagen binding ([Figure 9A](#f9-cmar-11-2379){ref-type="fig"}). The DEGs in the black module were significantly enriched in SH3/SH2 adaptor activity and GTPase activator activity ([Figure 9B](#f9-cmar-11-2379){ref-type="fig"}). The DEGs in the brown module were significantly enriched in anion channel activity ([Figure 9C](#f9-cmar-11-2379){ref-type="fig"}). In KEGG analysis, we found that DEGs in turquoise module were significantly enriched in retinol metabolism, tyrosine metabolism and drug metabolism ([Figure 9D](#f9-cmar-11-2379){ref-type="fig"}). The DEGs in the black module were significantly enriched in adrenergic signaling in cardiomyocytes ([Figure 9E](#f9-cmar-11-2379){ref-type="fig"}). The DEGs in the brown module were significantly enriched in NOD-like receptor signaling pathway and tryptophan metabolism ([Figure 9F](#f9-cmar-11-2379){ref-type="fig"}).

Using the WGCNA package, we found that the turquoise module had the highest correlation and negative cor relation with EOC. We speculated that the genes in the turquoise module may act as tumor suppressors. Defined by module connectivity, measured by absolute value of the Pearson's correlation (cor.geneModuleMembership \>0.85) and defined by tumor trait relationship, measured by absolute value of the Pearson's correlation (cor.geneTrait-Significance \>0.2), we found 40 hub genes belong to turquoise module. Next we combined survival analysis ([Table S6](#SD1-cmar-11-2379){ref-type="supplementary-material"}) and found that expression levels of *ADH1C, SNCA, ITLN1, PRSS35*, and *OGN* were significantly related to the overall survival of patients with EOC (*P*\<0.05) ([Figure S4](#SD1-cmar-11-2379){ref-type="supplementary-material"}). Furthermore, we found that patients with higher levels of *ITLN1* expression in vivo had longer overall survival than patients with lower expression levels ([Figure 10A](#f10-cmar-11-2379){ref-type="fig"}). Among the above five genes, only *ITLN1* was consistent with our speculation. Finally, we used qRT-PCR to perform the *ITLN1* validation. We found *ITLN1* was downregulated in EOC tissues that was compared with the normal ovarian tissues ([Figure 10B](#f10-cmar-11-2379){ref-type="fig"}).

Two other datasets and GEPIA were utilized to validate the expression of this gene. The results showed that *ITLN1* expression was strikingly higher in normal tissues compared to that of EOC tissues (*P*\<0.05) ([Figure 10C--E](#f10-cmar-11-2379){ref-type="fig"}).

Discussion
==========

EOC is a malignant tumor with high malignancy and extremely high mortality. Its progression and development have complex mechanisms. Little is known about it. Surgery and adjuvant therapy have limited prognosis for advanced EOC. Targeted therapy has become the most promising treatment for EOC. Therefore, it is very important to study biomarkers and related regulatory pathways that affect the development of EOC. In this research, we examined the gene expression profile of GSE18520 and GSE27651 that contained 96 samples of EOC tissue and 16 samples of normal ovarian tissue samples to identify the molecular mechanism of EOC and seek some biomarkers. Bioinformatics analysis of these biological factors is used to seek genes that are beneficial to treatment.

In these findings, we identified 1,700 DEGs associated with EOC, including 943 upregulated genes and 757 downregulated genes using *P*\<0.05 and \|logFC\|≥1 as the cutoff criteria, as shown in the volcano map ([Figure 2A](#f2-cmar-11-2379){ref-type="fig"}). We identified the top 100 DEGs according to \|logFC\|≥1 and then displayed on a heatmap. In GO analysis, the upregulated genes were mostly enriched in phosphate ion binding, the downregulated genes were highly enriched in glycosaminoglycan binding, heparin binding and sulfur compound binding. In the KEGG analy sis, the upregulated genes were mostly enriched in oxidative phosphorylation and cell cycle. The downregulated genes were mostly enriched in complement and coagulation cascades, and proteoglycans in cancer. The above enrichment analysis results can help us further study the role of DEGs in EOC.

Most of the above GO terms and pathways had a certain relationship with ovarian function. Li et al[@b31-cmar-11-2379] found that sphingosine-1-phosphate could prevent chemotherapy-induced human primordial follicle death. Giordano et al[@b32-cmar-11-2379] performed the evaluation of endometrial sulfate glycosaminoglycans in patients with polycystic ovary syndrome and found that they were closely related. Cree-Green et al[@b33-cmar-11-2379] found that peripheral insulin resistance in obese girls with hyperandrogenism was related to oxidative phosphorylation and elevated serum free fatty acids. As is known, obesity and elevated androgen are also the causes of weakening ovarian function. Oxidative metabolism and oxidative damage were widely considered as significant pathways in cancers, including EOC.[@b34-cmar-11-2379] Chen et al[@b35-cmar-11-2379] found that chemically modified heparin inhibited in vitro L-selectin-mediated human ovarian carcinoma cell adhesion. And the change of cell cycle was one of the factors that induced the occurrence of ovarian cancer. Many studies were also aimed at the cell cycle to find ways to treat ovarian cancer, for instance, Xiong et al[@b36-cmar-11-2379] found that ferruginol exhibited anticancer effects in OVCAR-3 human ovary cancer cells by inducing apoptosis, inhibition of cancer cell migration and G2/M phase cell cycle arrest.

We utilized PPI network analysis and WGCNA analysis to select PPI and gene co-expression modules that are linked to the clinical development of EOC. The PPI network was built on the DEGs that is analyzed by STRING website and Cytoscape software. Referring to cutoff of a k-core of 2, we found 7 clusters, among which cluster 1 had the highest score, and included 7 nodes and 21 edges in this subnetwork. Ten prominent proteins were also identified, among which CDK1 was considered to be the most important protein.

WGCNA analysis showed that three modules possessed exceedingly relevant expression pattern. For each module, GO and KEGG analysis were used to explore the biological process and pathway. The most relevant turquoise module contains 40 key genes. Through GO analysis, they were mainly enriched in collagen binding. In KEGG analysis, we found that DEGs in the turquoise module were highly enriched in retinol metabolism, tyrosine metabolism and drug metabolism. We performed further survival analysis and database validation of these genes. Interestingly, *ITLN1* was positively associated with the prognosis of EOC. We further performed the validation in the clinical tissues samples, and then found the expression level of *ITLN1* was lower in EOC tissues, consistent with the results predicted in GEPIA.

Our research found that CDK1 has 94 nodes in the PPI network, and ranked first. Cdk1 (cyclin-dependent kinase 1) is essential regulator of the G2-M checkpoint. Cyclin-dependent kinase pathways are considered potential targets for cancer treatment.[@b37-cmar-11-2379],[@b38-cmar-11-2379] Sung et al[@b39-cmar-11-2379] found that high nuclear/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients. It also has been identified as a clinically functional prognostic biomarker in non-small-cell lung cancer and breast cancer.[@b40-cmar-11-2379]--[@b44-cmar-11-2379] CDK1 has been shown to be involved in the development of EOC in multiple studies, and its high expression levels lead to poor prognosis[@b45-cmar-11-2379],[@b46-cmar-11-2379] and CDK1 affects drug resistance in EOC.[@b47-cmar-11-2379] These results indicate that CDK1 may be an independent biomarker for the diagnosis of EOC as well as a potential therapeutic target, and this result is consistent with our findings.

Intelectin 1 (*ITLN1*), a secretory lectin, is also a plasma adipokine that is synthesized in visceral adipose tissue. *ITLN1* has anti-inflammatory, antiatherogenic, anti-cardiovascular disease and antidiabetic propertiesits.[@b48-cmar-11-2379] Plasma concentration changes in colorectal cancer and conditions associated with insulin resistance.[@b49-cmar-11-2379],[@b50-cmar-11-2379] Circulating *ITLN1* levels were negatively correlated with WHR and BMI and significantly decreased in renal cancer patients.[@b51-cmar-11-2379] It has been proved that circulating *ITLN1* levels were elevated in patients with Prostate cancer.[@b52-cmar-11-2379] *ITLN1* was demonstrated to be a tumor suppressor and is associated with improved survival in gastric cancer.[@b53-cmar-11-2379] Li et al[@b54-cmar-11-2379] illustrated that intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells. Zhang and Zhou[@b55-cmar-11-2379] illustrated that *ITLN1* promotes apoptosis through regulating Sirt1-dependent p53 deacetylation in hepatocellular carcinoma cells. Therefore, Szydło et al[@b56-cmar-11-2379] stated that it is reasonable to use *ITLN1* as a biomarker for predicting individual conditions, such as obesity, type 2 diabetes, pancreatitis, gastric cancer, lung cancer or colon cancer. However, the role of *ITLN1* in EOC has not been verified.

There were some limitations to this study. First, we did not analyze the detailed classification of tumors, such as tumor size, staging, grading, and prognosis. We will explore key genes and pathways in detail based on this clinical information in future research.

Conclusion
==========

Through a series of comprehensive analysis of bioinformatics, we can roughly screen the hub genes and pathways related to the progression of EOC, and target therapy for the extracted hub gene *ITLN1* and hub protein CDK1 which might greatly promote the prognosis of advanced EOC. However, these key genes and pathways still need to be tested in a large quantity of clinical specimens, and need to be analyzed and validated in combination with the individual conditions of clinical patients in order to finally determine the biological targets that are most beneficial to EOC.
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![Study design and data preprocessing.\
**Note:** Flow diagram of study.\
**Abbreviations:** DEGs, differentially expressed genes; EOC, epithelial ovarian cancer; GEO, Gene Expression Omnibus; GEPIA, Gene Expression Profiling Interactive Analysis; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; PPI, protein--protein interaction.](cmar-11-2379Fig1){#f1-cmar-11-2379}

![Identification of DEGs in EOC and the enrichment of these genes.\
**Notes:** (**A**) The volcano plot of all DEGs. (**B**) Heatmap of the top 100 DEGs according to the value of \|logFC\|. Drawing of heatmap was performed through the "heatmap" package in R 3.4.4. (**C**) In GO analysis of DEGs, upregulated DEGs with fold change \>1. (**D**) In GO analysis of DEGs, downregulated DEGs with fold change \>1. (**E**) In KEGG analysis of DEGs, upregulated DEGs with fold change \>1. (**F**) In KEGG analysis of DEGs, downregulated DEGs with fold change \>1.\
**Abbreviations:** adj.P.val, adjusted *P*-value; DEGs, differentially expressed genes; FC, fold change; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; NoDEG, non-DEG.](cmar-11-2379Fig2){#f2-cmar-11-2379}

![Cluster analysis of the PPI network.\
**Notes:** (**A**) 1,700 DEGs were filtered into the DEGs PPI network complex that contained 1,467 nodes and 185 edges. (**B**) Histogram of key proteins. The *y*-axis represents the name of genes, the *x*-axis represents the number of adjacent genes, and height is the number of gene connections.\
**Abbreviations:** DEGs, differentially expressed genes; PPI, protein--protein interaction.](cmar-11-2379Fig3){#f3-cmar-11-2379}

![Module analysis of PPI network.\
**Notes:** (**A**) Module rank 1. This cluster contained 7 nodes and 21 edges and has the highest score in those clusters. (**B**) Module rank 2. This cluster contained 5 nodes and 10 edges and had the second highest score in those clusters.\
**Abbreviation:** PPI, protein--protein interaction.](cmar-11-2379Fig4){#f4-cmar-11-2379}

![Determination of soft-thresholding power in WGCNA.\
**Notes:** (**A**) GO enrichment analysis of module rank 1, (**B**) KEGG analysis of module rank 1.\
**Abbreviations:** GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; WGCNA, Weighted Gene Expression Network Analysis.](cmar-11-2379Fig5){#f5-cmar-11-2379}

![Hub module selection.\
**Notes:** (**A**) Samples clustering of GSE18520 and GSE27651. The clustering was based on the expression data of differentially expressed genes between tumor samples and normal samples in EOC. The color intensity was proportional to tumor samples and normal samples. (**B**) Dendrogram of all differentially expressed genes clustered based on a dissimilarity measure (1-TOM). (**C**) Dendrogram of consensus module eigengenes obtained by WGCNA on the consensus correlation. The red line was the merging threshold, and groups of eigengenes below the threshold represent modules whose expressions profiles should be merged due to their similarity. (**D**) Correlation between modules and traits. The upper number in each cell referred to the correlation coefficient of each module in the trait, and the lower number was the corresponding P-value. Among them, the turquoise module was the most relevant module with cancer traits.\
**Abbreviation:** TOM, topological overlap matrix.](cmar-11-2379Fig6){#f6-cmar-11-2379}

![Select hub genes in hub modules.\
**Notes:** (**A**) A scatter plot of GS for epithelial ovarian cancer vs the MM in the turquoise module. Intramodular analysis of the genes found in the turquoise module, which contained genes that had a high correlation with epithelial ovarian cancer, with *P*\<1.5e--125 and correlation =0.91. (**B**) A heatmap of all genes. The intensity of the red color indicated the strength of the correlation between pairs of modules on a linear scale. (**C**) Dendrogram of merged module eigengenes obtained by WGCNA. Heatmap plot of the adjacencies of modules. Red represented high adjacency (positive correlation) and blue represented low adjacency (negative correlation).\
**Abbreviations:** GS, gene significance; MM, module membership; WGCNA, Weighted Gene Expression Network Analysis.](cmar-11-2379Fig7){#f7-cmar-11-2379}

![PPI network of genes in the top three modules.\
**Notes:** The turquoise nodes represent the genes in turquoise module. The black nodes represent the genes in black module. The brown nodes represent the genes in brown module. Red words represent upregulated genes and blue words represent downregulated genes. The network was constructed using Cytoscape 3.4 software. **Abbreviation:** PPI, protein--protein interaction.](cmar-11-2379Fig8){#f8-cmar-11-2379}

![GO and KEGG enrichment analysis of three genes modules.\
**Note:** (**A**) GO analysis of turquoise module; (**B**) GO analysis of black module; (**C**) GO analysis of brown module; (**D**) KEGG analysis of turquoise module; (**E**) KEGG analysis of black module; (**F**) KEGG analysis of brown module.**Abbreviations:** GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes.](cmar-11-2379Fig9){#f9-cmar-11-2379}

![Validation of hub genes.\
**Notes:** (**A**) Survival analysis indicated that *ITLN1* was a positive prognosis factor in epithelial ovarian cancer, while patients with a higher expression of *ITLN1* had significantly longer overall survival compared to those with higher expression (*P*=2.593e--02). (**B**) *ITLN1* validation using qRT-PCR analysis. (**C, D**) Validation of *ITLN1* expression from the GEO databases. Two datasets showed lower expression of *ITLN1* in epithelial ovarian cancer tissues compared with normal ovarian tissues (*P*\<0.001). (**E**) Validation of *ITLN1* expression in GEPIA. Lower expression of *ITLN1* in tumor tissues compared with normal ovarian tissues. \*\*\**P*\<0.001; \*\**P*\<0.01; \**P*\<0.05.\
**Abbreviations:** GEO, Gene Expression Omnibus; GEPIA, Gene Expression Profiling Interactive Analysis; num(T), number of tumor sample, num(N), number of normal sample; OV, ovarian cancer; qRT-PCR, quantitative real-time RT-PCR.](cmar-11-2379Fig10){#f10-cmar-11-2379}
